Literature DB >> 11874886

Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction.

George Hajishengallis1, Michael Martin, Hakimuddin T Sojar, Ashu Sharma, Robert E Schifferle, Ernesto DeNardin, Michael W Russell, Robert J Genco.   

Abstract

Toll-like receptors (TLRs) are important signal transducers that mediate inflammatory reactions induced by microbes through pattern recognition of virulence molecules such as lipopolysaccharide (LPS) and lipoproteins. We investigated whether proinflammatory cytokine responses induced by certain bacterial protein adhesins may also depend on TLRs. In differentiated THP-1 mononuclear cells stimulated by LPS-free recombinant fimbrillin (rFimA) from Porphyromonas gingivalis, cytokine release was abrogated by monoclonal antibodies (MAbs) to CD14 and TLR4 but not to TLR2. Similar experiments using anti-beta2 integrin MAbs suggested that beta2 integrins (CD11/CD18) also play a role in cytokine induction by rFimA or native fimbriae. Minor fimbriae (distinct from the fimA-encoded major fimbriae) of P. gingivalis induced proinflammatory cytokine release in a CD14- and TLR2-dependent mode. Cytokine induction by BspA, a leucine-rich repeat protein from Bacteroides forsythus, depended heavily on CD14 and TLR2. We also found that the ability of the streptococcal protein AgI/II to stimulate cytokine release depended partially on CD14 and TLR4, and the AgI/II segment that possibly interacts with these receptors was identified as its N-terminal saliva-binding region. When THP-1 cells were exposed to rFimA for 24 h, surface expression of CD14 and CD18 was decreased and the cells became hyporesponsive to cytokine induction by a second challenge with rFimA. However, tolerance induction was abolished when the THP-1 cells were pretreated with rFimA in the presence of either anti-CD14 MAb or anti-TLR4 MAb. Induction of cross-tolerance between rFimA and LPS correlated with downregulation of the pattern recognition receptors involved. Our data suggest that the CD14-TLR2/4 system is involved in cytokine production and tolerance induction upon interaction with certain proinflammatory bacterial protein adhesins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874886      PMCID: PMC119939          DOI: 10.1128/cdli.9.2.403-411.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  54 in total

Review 1.  The Toll receptor family and microbial recognition.

Authors:  R Medzhitov; C Janeway
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

Review 2.  Innate immunity.

Authors:  R Medzhitov; C Janeway
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

3.  Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340.

Authors:  A Prakobphol; F Xu; V M Hoang; T Larsson; J Bergstrom; I Johansson; L Frängsmyr; U Holmskov; H Leffler; C Nilsson; T Borén; J R Wright; N Strömberg; S J Fisher
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

4.  Regulation of macrophage activation markers by IL-4 and IFN-gamma is subpopulation-specific.

Authors:  I J Molina; B T Huber
Journal:  Cell Immunol       Date:  1991-04-15       Impact factor: 4.868

5.  Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.

Authors:  A E Medvedev; K M Kopydlowski; S N Vogel
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

6.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

8.  Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression.

Authors:  F Nomura; S Akashi; Y Sakao; S Sato; T Kawai; M Matsumoto; K Nakanishi; M Kimoto; K Miyake; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

9.  Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection.

Authors:  J Sandros; C Karlsson; D F Lappin; P N Madianos; D F Kinane; P N Papapanou
Journal:  J Dent Res       Date:  2000-10       Impact factor: 6.116

10.  CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.

Authors:  P Y Perera; T N Mayadas; O Takeuchi; S Akira; M Zaks-Zilberman; S M Goyert; S N Vogel
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

View more
  33 in total

1.  Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples.

Authors:  Frank C Nichols; Bekim Bajrami; Robert B Clark; William Housley; Xudong Yao
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Downregulation of the DNA-binding activity of nuclear factor-kappaB p65 subunit in Porphyromonas gingivalis fimbria-induced tolerance.

Authors:  George Hajishengallis; Robert J Genco
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

3.  Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling.

Authors:  Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

4.  Toll-like receptor 2-mediated interleukin-8 expression in gingival epithelial cells by the Tannerella forsythia leucine-rich repeat protein BspA.

Authors:  Shinsuke Onishi; Kiyonobu Honma; Shuang Liang; Panagiota Stathopoulou; Denis Kinane; George Hajishengallis; Ashu Sharma
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 5.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

6.  Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection.

Authors:  Eunjoo Park; Hee Sam Na; Yu-Ri Song; Seong Yeol Shin; You-Me Kim; Jin Chung
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

7.  Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion.

Authors:  Hiromichi Yumoto; Hsin-Hua Chou; Yusuke Takahashi; Michael Davey; Frank C Gibson; Caroline A Genco
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Proteomic mapping of stimulus-specific signaling pathways involved in THP-1 cells exposed to Porphyromonas gingivalis or its purified components.

Authors:  Julian A Saba; Mark E McComb; Donna L Potts; Catherine E Costello; Salomon Amar
Journal:  J Proteome Res       Date:  2007-05-04       Impact factor: 4.466

9.  Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease.

Authors:  Akira Hasebe; Atsutoshi Yoshimura; Takeshi Into; Hideo Kataoka; Saori Tanaka; Shinichi Arakawa; Hiroaki Ishikura; Douglas T Golenbock; Tsutomu Sugaya; Nobuo Tsuchida; Masamitsu Kawanami; Yoshitaka Hara; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response.

Authors:  Ravi Jotwani; Christopher W Cutler
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.